ID   TNR21_HUMAN             Reviewed;         655 AA.
AC   O75509; B2RDI9; Q0D2P5; Q96D86;
DT   27-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 1.
DT   10-MAY-2017, entry version 162.
DE   RecName: Full=Tumor necrosis factor receptor superfamily member 21;
DE   AltName: Full=Death receptor 6;
DE   AltName: CD_antigen=CD358;
DE   Flags: Precursor;
GN   Name=TNFRSF21; Synonyms=DR6; ORFNames=UNQ437/PRO868;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, AND
RP   INTERACTION WITH TRADD.
RX   PubMed=9714541; DOI=10.1016/S0014-5793(98)00791-1;
RA   Pan G., Bauer J.H., Haridas V., Wang S., Liu D., Yu G., Vincenz C.,
RA   Aggarwal B.B., Ni J., Dixit V.M.;
RT   "Identification and functional characterization of DR6, a novel death
RT   domain-containing TNF receptor.";
RL   FEBS Lett. 431:351-356(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, Colon, and Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   SUBCELLULAR LOCATION, GLYCOSYLATION AT ASN-82; ASN-141; ASN-252;
RP   ASN-257; ASN-278 AND ASN-289, MUTAGENESIS OF ASN-82; ASN-141; ASN-252;
RP   ASN-257; ASN-278 AND ASN-289, INDUCTION BY TNF, AND PALMITOYLATION AT
RP   CYS-368.
RX   PubMed=19654028; DOI=10.1016/j.bbamcr.2009.07.008;
RA   Klima M., Zajedova J., Doubravska L., Andera L.;
RT   "Functional analysis of the posttranslational modifications of the
RT   death receptor 6.";
RL   Biochim. Biophys. Acta 1793:1579-1587(2009).
RN   [8]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=21725297; DOI=10.1038/nm.2373;
RA   Mi S., Lee X., Hu Y., Ji B., Shao Z., Yang W., Huang G., Walus L.,
RA   Rhodes K., Gong B.J., Miller R.H., Pepinsky R.B.;
RT   "Death receptor 6 negatively regulates oligodendrocyte survival,
RT   maturation and myelination.";
RL   Nat. Med. 17:816-821(2011).
RN   [9]
RP   FUNCTION.
RX   PubMed=22761420; DOI=10.1074/jbc.M112.362038;
RA   Zeng L., Li T., Xu D.C., Liu J., Mao G., Cui M.Z., Fu X., Xu X.;
RT   "Death receptor 6 induces apoptosis not through type I or type II
RT   pathways, but via a unique mitochondria-dependent pathway by
RT   interacting with Bax protein.";
RL   J. Biol. Chem. 287:29125-29133(2012).
RN   [10]
RP   INDUCTION, TISSUE SPECIFICITY, AND INTERACTION WITH NGFR.
RX   PubMed=23559013; DOI=10.1038/cddis.2013.110;
RA   Hu Y., Lee X., Shao Z., Apicco D., Huang G., Gong B.J., Pepinsky R.B.,
RA   Mi S.;
RT   "A DR6/p75(NTR) complex is responsible for beta-amyloid-induced
RT   cortical neuron death.";
RL   Cell Death Dis. 4:E579-E579(2013).
RN   [11]
RP   STRUCTURE BY NMR OF 562-655.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the carboxyl-terminal CARD-like domain in human
RT   TNFR-related death receptor-6.";
RL   Submitted (DEC-2006) to the PDB data bank.
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 42-218, AND DISULFIDE BOND.
RX   PubMed=21463639; DOI=10.1016/j.jmb.2011.03.048;
RA   Kuester M., Kemmerzehl S., Dahms S.O., Roeser D., Than M.E.;
RT   "The crystal structure of death receptor 6 (DR6): a potential receptor
RT   of the amyloid precursor protein (APP).";
RL   J. Mol. Biol. 409:189-201(2011).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.09 ANGSTROMS) OF 42-349, DISULFIDE BOND, AND
RP   GLYCOSYLATION.
RX   PubMed=22525750; DOI=10.1107/S0907444912004490;
RA   Ru H., Zhao L., Ding W., Jiao L., Shaw N., Liang W., Zhang L.,
RA   Hung L.W., Matsugaki N., Wakatsuki S., Liu Z.J.;
RT   "S-SAD phasing study of death receptor 6 and its solution conformation
RT   revealed by SAXS.";
RL   Acta Crystallogr. D 68:521-530(2012).
CC   -!- FUNCTION: Promotes apoptosis, possibly via a pathway that involves
CC       the activation of NF-kappa-B. Can also promote apoptosis mediated
CC       by BAX and by the release of cytochrome c from the mitochondria
CC       into the cytoplasm. Plays a role in neuronal apoptosis, including
CC       apoptosis in response to amyloid peptides derived from APP, and is
CC       required for both normal cell body death and axonal pruning.
CC       Trophic-factor deprivation triggers the cleavage of surface APP by
CC       beta-secretase to release sAPP-beta which is further cleaved to
CC       release an N-terminal fragment of APP (N-APP). N-APP binds
CC       TNFRSF21; this triggers caspase activation and degeneration of
CC       both neuronal cell bodies (via caspase-3) and axons (via caspase-
CC       6). Negatively regulates oligodendrocyte survival, maturation and
CC       myelination. Plays a role in signaling cascades triggered by
CC       stimulation of T-cell receptors, in the adaptive immune response
CC       and in the regulation of T-cell differentiation and proliferation.
CC       Negatively regulates T-cell responses and the release of cytokines
CC       such as IL4, IL5, IL10, IL13 and IFNG by Th2 cells. Negatively
CC       regulates the production of IgG, IgM and IgM in response to
CC       antigens. May inhibit the activation of JNK in response to T-cell
CC       stimulation. {ECO:0000269|PubMed:21725297,
CC       ECO:0000269|PubMed:22761420, ECO:0000269|PubMed:9714541}.
CC   -!- SUBUNIT: Interacts with N-APP (By similarity). Associates with
CC       TRADD. Interacts with NGFR. {ECO:0000250,
CC       ECO:0000269|PubMed:23559013, ECO:0000269|PubMed:9714541}.
CC   -!- INTERACTION:
CC       P05067:APP; NbExp=3; IntAct=EBI-2313231, EBI-77613;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:19654028};
CC       Single-pass type I membrane protein {ECO:0000269|PubMed:19654028}.
CC   -!- TISSUE SPECIFICITY: Detected in fetal spinal cord and in brain
CC       neurons, with higher levels in brain from Alzheimer disease
CC       patients (at protein level). Highly expressed in heart, brain,
CC       placenta, pancreas, lymph node, thymus and prostate. Detected at
CC       lower levels in lung, skeletal muscle, kidney, testis, uterus,
CC       small intestine, colon, spleen, bone marrow and fetal liver. Very
CC       low levels were found in adult liver and peripheral blood
CC       leukocytes. {ECO:0000269|PubMed:21725297,
CC       ECO:0000269|PubMed:23559013, ECO:0000269|PubMed:9714541}.
CC   -!- INDUCTION: Up-regulated by TNF. {ECO:0000269|PubMed:19654028,
CC       ECO:0000269|PubMed:23559013}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-25 is the initiator.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH10241.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF068868; AAC34583.1; -; mRNA.
DR   EMBL; AY358304; AAQ88671.1; -; mRNA.
DR   EMBL; AK315560; BAG37936.1; -; mRNA.
DR   EMBL; BT007420; AAP36088.1; -; mRNA.
DR   EMBL; AL096801; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC010241; AAH10241.1; ALT_INIT; mRNA.
DR   EMBL; BC017730; AAH17730.1; -; mRNA.
DR   EMBL; BC021572; AAH21572.1; -; mRNA.
DR   CCDS; CCDS4921.1; -.
DR   RefSeq; NP_055267.1; NM_014452.4.
DR   UniGene; Hs.443577; -.
DR   PDB; 2DBH; NMR; -; A=567-655.
DR   PDB; 3QO4; X-ray; 2.20 A; A=42-218.
DR   PDB; 3U3P; X-ray; 2.09 A; A=42-348.
DR   PDB; 3U3Q; X-ray; 2.70 A; A=42-348.
DR   PDB; 3U3S; X-ray; 2.70 A; A=42-348.
DR   PDB; 3U3T; X-ray; 3.21 A; A=42-348.
DR   PDB; 3U3V; X-ray; 2.96 A; A=42-348.
DR   PDBsum; 2DBH; -.
DR   PDBsum; 3QO4; -.
DR   PDBsum; 3U3P; -.
DR   PDBsum; 3U3Q; -.
DR   PDBsum; 3U3S; -.
DR   PDBsum; 3U3T; -.
DR   PDBsum; 3U3V; -.
DR   ProteinModelPortal; O75509; -.
DR   SMR; O75509; -.
DR   BioGrid; 118090; 9.
DR   DIP; DIP-53299N; -.
DR   IntAct; O75509; 6.
DR   MINT; MINT-8247609; -.
DR   STRING; 9606.ENSP00000296861; -.
DR   iPTMnet; O75509; -.
DR   PhosphoSitePlus; O75509; -.
DR   EPD; O75509; -.
DR   MaxQB; O75509; -.
DR   PaxDb; O75509; -.
DR   PeptideAtlas; O75509; -.
DR   PRIDE; O75509; -.
DR   DNASU; 27242; -.
DR   Ensembl; ENST00000296861; ENSP00000296861; ENSG00000146072.
DR   GeneID; 27242; -.
DR   KEGG; hsa:27242; -.
DR   UCSC; uc003oyv.5; human.
DR   CTD; 27242; -.
DR   DisGeNET; 27242; -.
DR   GeneCards; TNFRSF21; -.
DR   HGNC; HGNC:13469; TNFRSF21.
DR   HPA; CAB009805; -.
DR   HPA; HPA006746; -.
DR   MIM; 605732; gene.
DR   neXtProt; NX_O75509; -.
DR   OpenTargets; ENSG00000146072; -.
DR   PharmGKB; PA37775; -.
DR   eggNOG; ENOG410IHQ6; Eukaryota.
DR   eggNOG; ENOG410YYKW; LUCA.
DR   GeneTree; ENSGT00760000119204; -.
DR   HOGENOM; HOG000136852; -.
DR   HOVERGEN; HBG054218; -.
DR   InParanoid; O75509; -.
DR   KO; K05157; -.
DR   OMA; FSRPEHM; -.
DR   OrthoDB; EOG091G03XW; -.
DR   PhylomeDB; O75509; -.
DR   TreeFam; TF331157; -.
DR   Reactome; R-HSA-1989781; PPARA activates gene expression.
DR   SIGNOR; O75509; -.
DR   ChiTaRS; TNFRSF21; human.
DR   EvolutionaryTrace; O75509; -.
DR   GeneWiki; TNFRSF21; -.
DR   GenomeRNAi; 27242; -.
DR   PRO; PR:O75509; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000146072; -.
DR   CleanEx; HS_TNFRSF21; -.
DR   ExpressionAtlas; O75509; baseline and differential.
DR   Genevisible; O75509; HS.
DR   GO; GO:0030424; C:axon; IEA:Ensembl.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0031226; C:intrinsic component of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005031; F:tumor necrosis factor-activated receptor activity; IBA:GO_Central.
DR   GO; GO:0002250; P:adaptive immune response; ISS:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; IMP:UniProtKB.
DR   GO; GO:0097190; P:apoptotic signaling pathway; IBA:GO_Central.
DR   GO; GO:0001783; P:B cell apoptotic process; ISS:UniProtKB.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; IDA:UniProtKB.
DR   GO; GO:0006959; P:humoral immune response; ISS:UniProtKB.
DR   GO; GO:0006955; P:immune response; IBA:GO_Central.
DR   GO; GO:0006954; P:inflammatory response; IBA:GO_Central.
DR   GO; GO:0042552; P:myelination; ISS:UniProtKB.
DR   GO; GO:0030889; P:negative regulation of B cell proliferation; ISS:UniProtKB.
DR   GO; GO:2001180; P:negative regulation of interleukin-10 secretion; ISS:UniProtKB.
DR   GO; GO:2000666; P:negative regulation of interleukin-13 secretion; ISS:UniProtKB.
DR   GO; GO:2000663; P:negative regulation of interleukin-5 secretion; ISS:UniProtKB.
DR   GO; GO:0031642; P:negative regulation of myelination; IMP:UniProtKB.
DR   GO; GO:0042130; P:negative regulation of T cell proliferation; ISS:UniProtKB.
DR   GO; GO:0051402; P:neuron apoptotic process; ISS:UniProtKB.
DR   GO; GO:0097252; P:oligodendrocyte apoptotic process; ISS:UniProtKB.
DR   GO; GO:0042981; P:regulation of apoptotic process; IBA:GO_Central.
DR   GO; GO:0042127; P:regulation of cell proliferation; IBA:GO_Central.
DR   GO; GO:0048713; P:regulation of oligodendrocyte differentiation; ISS:UniProtKB.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IBA:GO_Central.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; ISS:UniProtKB.
DR   CDD; cd08778; Death_TNFRSF21; 1.
DR   CDD; cd10583; TNFRSF21; 1.
DR   InterPro; IPR011029; DEATH-like_dom.
DR   InterPro; IPR000488; Death_domain.
DR   InterPro; IPR001368; TNFR/NGFR_Cys_rich_reg.
DR   InterPro; IPR022330; TNFR_21.
DR   InterPro; IPR034037; TNFRSF21_death.
DR   InterPro; IPR034034; TNFRSF21_N.
DR   InterPro; IPR011641; Tyr-kin_ephrin_A/B_rcpt-like.
DR   Pfam; PF00531; Death; 1.
DR   Pfam; PF00020; TNFR_c6; 3.
DR   PRINTS; PR01971; TNFACTORR21.
DR   SMART; SM00005; DEATH; 1.
DR   SMART; SM01411; Ephrin_rec_like; 2.
DR   SMART; SM00208; TNFR; 4.
DR   SUPFAM; SSF47986; SSF47986; 1.
DR   PROSITE; PS50017; DEATH_DOMAIN; 1.
DR   PROSITE; PS00652; TNFR_NGFR_1; 1.
DR   PROSITE; PS50050; TNFR_NGFR_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Adaptive immunity; Apoptosis; Cell membrane;
KW   Complete proteome; Disulfide bond; Glycoprotein; Immunity;
KW   Lipoprotein; Membrane; Palmitate; Receptor; Reference proteome;
KW   Repeat; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     41       {ECO:0000255}.
FT   CHAIN        42    655       Tumor necrosis factor receptor
FT                                superfamily member 21.
FT                                /FTId=PRO_0000034602.
FT   TOPO_DOM     42    349       Extracellular. {ECO:0000255}.
FT   TRANSMEM    350    370       Helical. {ECO:0000255}.
FT   TOPO_DOM    371    655       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       50     88       TNFR-Cys 1.
FT   REPEAT       90    131       TNFR-Cys 2.
FT   REPEAT      133    167       TNFR-Cys 3.
FT   REPEAT      170    211       TNFR-Cys 4.
FT   DOMAIN      415    498       Death. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00064}.
FT   LIPID       368    368       S-palmitoyl cysteine.
FT                                {ECO:0000269|PubMed:19654028}.
FT   CARBOHYD     82     82       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19654028}.
FT   CARBOHYD    141    141       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19654028}.
FT   CARBOHYD    252    252       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19654028}.
FT   CARBOHYD    257    257       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19654028}.
FT   CARBOHYD    278    278       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19654028}.
FT   CARBOHYD    289    289       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19654028}.
FT   DISULFID     67     80
FT   DISULFID     70     88
FT   DISULFID     91    106
FT   DISULFID    109    123
FT   DISULFID    113    131
FT   DISULFID    133    144
FT   DISULFID    150    168
FT   DISULFID    171    186
FT   DISULFID    192    211
FT   MUTAGEN      82     82       N->Q: Abolishes one glycosylation site
FT                                and reduces total N-glycosylation; when
FT                                associated with Q-252; Q-278 and Q-289.
FT                                {ECO:0000269|PubMed:19654028}.
FT   MUTAGEN     141    141       N->Q: Abolishes one glycosylation site
FT                                and reduces total N-glycosylation; when
FT                                associated with Q-82; Q-252; Q-278 and Q-
FT                                289. {ECO:0000269|PubMed:19654028}.
FT   MUTAGEN     252    252       N->Q: Abolishes one glycosylation site
FT                                and reduces total N-glycosylation; when
FT                                associated with Q-278 and Q-289.
FT                                {ECO:0000269|PubMed:19654028}.
FT   MUTAGEN     257    257       N->Q: Abolishes one glycosylation site
FT                                and reduces total N-glycosylation; when
FT                                associated with Q-82; Q-141; Q-252; Q-278
FT                                and Q-289. {ECO:0000269|PubMed:19654028}.
FT   MUTAGEN     278    278       N->Q: Abolishes one glycosylation site
FT                                and reduces total N-glycosylation.
FT                                Abolishes one glycosylation site and
FT                                reduces total N-glycosylation; when
FT                                associated with Q-82; Q-141; Q-252; Q-257
FT                                and Q-289. {ECO:0000269|PubMed:19654028}.
FT   MUTAGEN     289    289       N->Q: Abolishes one glycosylation site
FT                                and reduces total N-glycosylation; when
FT                                associated with Q-278.
FT                                {ECO:0000269|PubMed:19654028}.
FT   MUTAGEN     368    368       C->V: Abolishes palmitoylation.
FT   STRAND       53     57       {ECO:0000244|PDB:3U3P}.
FT   TURN         59     61       {ECO:0000244|PDB:3U3P}.
FT   STRAND       64     68       {ECO:0000244|PDB:3U3P}.
FT   STRAND       74     78       {ECO:0000244|PDB:3U3P}.
FT   STRAND       82     84       {ECO:0000244|PDB:3U3T}.
FT   STRAND       87     90       {ECO:0000244|PDB:3U3P}.
FT   STRAND       99    101       {ECO:0000244|PDB:3U3V}.
FT   STRAND      118    121       {ECO:0000244|PDB:3U3P}.
FT   STRAND      130    132       {ECO:0000244|PDB:3U3P}.
FT   STRAND      137    140       {ECO:0000244|PDB:3U3P}.
FT   STRAND      143    146       {ECO:0000244|PDB:3U3P}.
FT   STRAND      154    158       {ECO:0000244|PDB:3U3P}.
FT   STRAND      162    164       {ECO:0000244|PDB:3U3P}.
FT   STRAND      167    170       {ECO:0000244|PDB:3U3P}.
FT   STRAND      181    183       {ECO:0000244|PDB:3U3P}.
FT   HELIX       193    195       {ECO:0000244|PDB:3U3P}.
FT   STRAND      198    201       {ECO:0000244|PDB:3U3P}.
FT   STRAND      205    207       {ECO:0000244|PDB:3U3P}.
FT   STRAND      210    212       {ECO:0000244|PDB:3U3P}.
FT   STRAND      571    573       {ECO:0000244|PDB:2DBH}.
FT   HELIX       579    591       {ECO:0000244|PDB:2DBH}.
FT   HELIX       598    606       {ECO:0000244|PDB:2DBH}.
FT   HELIX       609    616       {ECO:0000244|PDB:2DBH}.
FT   HELIX       621    635       {ECO:0000244|PDB:2DBH}.
FT   HELIX       637    650       {ECO:0000244|PDB:2DBH}.
FT   HELIX       652    654       {ECO:0000244|PDB:2DBH}.
SQ   SEQUENCE   655 AA;  71845 MW;  48939391C4852A33 CRC64;
     MGTSPSSSTA LASCSRIARR ATATMIAGSL LLLGFLSTTT AQPEQKASNL IGTYRHVDRA
     TGQVLTCDKC PAGTYVSEHC TNTSLRVCSS CPVGTFTRHE NGIEKCHDCS QPCPWPMIEK
     LPCAALTDRE CTCPPGMFQS NATCAPHTVC PVGWGVRKKG TETEDVRCKQ CARGTFSDVP
     SSVMKCKAYT DCLSQNLVVI KPGTKETDNV CGTLPSFSSS TSPSPGTAIF PRPEHMETHE
     VPSSTYVPKG MNSTESNSSA SVRPKVLSSI QEGTVPDNTS SARGKEDVNK TLPNLQVVNH
     QQGPHHRHIL KLLPSMEATG GEKSSTPIKG PKRGHPRQNL HKHFDINEHL PWMIVLFLLL
     VLVVIVVCSI RKSSRTLKKG PRQDPSAIVE KAGLKKSMTP TQNREKWIYY CNGHGIDILK
     LVAAQVGSQW KDIYQFLCNA SEREVAAFSN GYTADHERAY AALQHWTIRG PEASLAQLIS
     ALRQHRRNDV VEKIRGLMED TTQLETDKLA LPMSPSPLSP SPIPSPNAKL ENSALLTVEP
     SPQDKNKGFF VDESEPLLRC DSTSSGSSAL SRNGSFITKE KKDTVLRQVR LDPCDLQPIF
     DDMLHFLNPE ELRVIEEIPQ AEDKLDRLFE IIGVKSQEAS QTLLDSVYSH LPDLL
//
